Cargando…

Somatic evolutionary timings of driver mutations

BACKGROUND: A unified analysis of DNA sequences from hundreds of tumors concluded that the driver mutations primarily occur in the earliest stages of cancer formation, with relatively few driver mutation events detected in the late-arising subclones. However, emerging evidence from the sequencing of...

Descripción completa

Detalles Bibliográficos
Autores principales: Gomez, Karen, Miura, Sayaka, Huuki, Louise A., Spell, Brianna S., Townsend, Jeffrey P., Kumar, Sudhir
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5774140/
https://www.ncbi.nlm.nih.gov/pubmed/29347918
http://dx.doi.org/10.1186/s12885-017-3977-y
_version_ 1783293710551744512
author Gomez, Karen
Miura, Sayaka
Huuki, Louise A.
Spell, Brianna S.
Townsend, Jeffrey P.
Kumar, Sudhir
author_facet Gomez, Karen
Miura, Sayaka
Huuki, Louise A.
Spell, Brianna S.
Townsend, Jeffrey P.
Kumar, Sudhir
author_sort Gomez, Karen
collection PubMed
description BACKGROUND: A unified analysis of DNA sequences from hundreds of tumors concluded that the driver mutations primarily occur in the earliest stages of cancer formation, with relatively few driver mutation events detected in the late-arising subclones. However, emerging evidence from the sequencing of multiple tumors and tumor regions per individual suggests that late-arising subclones with additional driver mutations are underestimated in single-sample analyses. METHODS: To test whether driver mutations generally map to early tumor development, we examined multi-regional tumor sequencing data from 101 individuals reported in 11 published studies. Following previous studies, we annotated mutations as early-arising when all tumors/regions had those mutations (ubiquitous). We then inferred the fraction of mutations occurring early and compared it with late-arising mutations that were found in only single tumors/regions. RESULTS: While a large fraction of driver mutations in tumors occurred relatively early in cancers, later driver mutations occurred at least as frequently as the early drivers in a substantial number of patients. This result was robust to many different approaches to annotate driver mutations. The relative frequency of early and late driver mutations varied among patients of the same cancer type and in different cancer types. We found that previous reports of the preponderance of early driver mutations were primarily informed by analysis of single tumor variant allele profiles, with which it is challenging to clearly distinguish between early and late drivers. CONCLUSIONS: The origin and preponderance of new driver mutations are not limited to early stages of tumor evolution, with different tumors and regions showing distinct driver mutations and, consequently, distinct characteristics. Therefore, tumors with extensive intratumor heterogeneity appear to have many newly acquired drivers. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi: 10.1186/s12885-017-3977-y) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-5774140
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-57741402018-01-26 Somatic evolutionary timings of driver mutations Gomez, Karen Miura, Sayaka Huuki, Louise A. Spell, Brianna S. Townsend, Jeffrey P. Kumar, Sudhir BMC Cancer Research Article BACKGROUND: A unified analysis of DNA sequences from hundreds of tumors concluded that the driver mutations primarily occur in the earliest stages of cancer formation, with relatively few driver mutation events detected in the late-arising subclones. However, emerging evidence from the sequencing of multiple tumors and tumor regions per individual suggests that late-arising subclones with additional driver mutations are underestimated in single-sample analyses. METHODS: To test whether driver mutations generally map to early tumor development, we examined multi-regional tumor sequencing data from 101 individuals reported in 11 published studies. Following previous studies, we annotated mutations as early-arising when all tumors/regions had those mutations (ubiquitous). We then inferred the fraction of mutations occurring early and compared it with late-arising mutations that were found in only single tumors/regions. RESULTS: While a large fraction of driver mutations in tumors occurred relatively early in cancers, later driver mutations occurred at least as frequently as the early drivers in a substantial number of patients. This result was robust to many different approaches to annotate driver mutations. The relative frequency of early and late driver mutations varied among patients of the same cancer type and in different cancer types. We found that previous reports of the preponderance of early driver mutations were primarily informed by analysis of single tumor variant allele profiles, with which it is challenging to clearly distinguish between early and late drivers. CONCLUSIONS: The origin and preponderance of new driver mutations are not limited to early stages of tumor evolution, with different tumors and regions showing distinct driver mutations and, consequently, distinct characteristics. Therefore, tumors with extensive intratumor heterogeneity appear to have many newly acquired drivers. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi: 10.1186/s12885-017-3977-y) contains supplementary material, which is available to authorized users. BioMed Central 2018-01-18 /pmc/articles/PMC5774140/ /pubmed/29347918 http://dx.doi.org/10.1186/s12885-017-3977-y Text en © The Author(s). 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Gomez, Karen
Miura, Sayaka
Huuki, Louise A.
Spell, Brianna S.
Townsend, Jeffrey P.
Kumar, Sudhir
Somatic evolutionary timings of driver mutations
title Somatic evolutionary timings of driver mutations
title_full Somatic evolutionary timings of driver mutations
title_fullStr Somatic evolutionary timings of driver mutations
title_full_unstemmed Somatic evolutionary timings of driver mutations
title_short Somatic evolutionary timings of driver mutations
title_sort somatic evolutionary timings of driver mutations
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5774140/
https://www.ncbi.nlm.nih.gov/pubmed/29347918
http://dx.doi.org/10.1186/s12885-017-3977-y
work_keys_str_mv AT gomezkaren somaticevolutionarytimingsofdrivermutations
AT miurasayaka somaticevolutionarytimingsofdrivermutations
AT huukilouisea somaticevolutionarytimingsofdrivermutations
AT spellbriannas somaticevolutionarytimingsofdrivermutations
AT townsendjeffreyp somaticevolutionarytimingsofdrivermutations
AT kumarsudhir somaticevolutionarytimingsofdrivermutations